These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

855 related items for PubMed ID: 10757977

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Crystallographic investigation of the inhibition mode of a VIM-2 metallo-beta-lactamase from Pseudomonas aeruginosa by a mercaptocarboxylate inhibitor.
    Yamaguchi Y, Jin W, Matsunaga K, Ikemizu S, Yamagata Y, Wachino J, Shibata N, Arakawa Y, Kurosaki H.
    J Med Chem; 2007 Dec 27; 50(26):6647-53. PubMed ID: 18052313
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-beta-lactamase.
    Toney JH, Fitzgerald PM, Grover-Sharma N, Olson SH, May WJ, Sundelof JG, Vanderwall DE, Cleary KA, Grant SK, Wu JK, Kozarich JW, Pompliano DL, Hammond GG.
    Chem Biol; 1998 Apr 27; 5(4):185-96. PubMed ID: 9545432
    [Abstract] [Full Text] [Related]

  • 6. Crystal structure of Pseudomonas aeruginosa SPM-1 provides insights into variable zinc affinity of metallo-beta-lactamases.
    Murphy TA, Catto LE, Halford SE, Hadfield AT, Minor W, Walsh TR, Spencer J.
    J Mol Biol; 2006 Mar 31; 357(3):890-903. PubMed ID: 16460758
    [Abstract] [Full Text] [Related]

  • 7. The structure of the metallo-β-lactamase VIM-2 in complex with a triazolylthioacetamide inhibitor.
    Christopeit T, Yang KW, Yang SK, Leiros HK.
    Acta Crystallogr F Struct Biol Commun; 2016 Nov 01; 72(Pt 11):813-819. PubMed ID: 27834790
    [Abstract] [Full Text] [Related]

  • 8. Antibiotic recognition by binuclear metallo-beta-lactamases revealed by X-ray crystallography.
    Spencer J, Read J, Sessions RB, Howell S, Blackburn GM, Gamblin SJ.
    J Am Chem Soc; 2005 Oct 19; 127(41):14439-44. PubMed ID: 16218639
    [Abstract] [Full Text] [Related]

  • 9. Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem.
    Pernot L, Frénois F, Rybkine T, L'Hermite G, Petrella S, Delettré J, Jarlier V, Collatz E, Sougakoff W.
    J Mol Biol; 2001 Jul 20; 310(4):859-74. PubMed ID: 11453693
    [Abstract] [Full Text] [Related]

  • 10. Structural and biochemical analysis of the metallo-β-lactamase L1 from emerging pathogen Stenotrophomonas maltophilia revealed the subtle but distinct di-metal scaffold for catalytic activity.
    Kim Y, Maltseva N, Wilamowski M, Tesar C, Endres M, Joachimiak A.
    Protein Sci; 2020 Mar 20; 29(3):723-743. PubMed ID: 31846104
    [Abstract] [Full Text] [Related]

  • 11. Exploring sequence requirements for C₃/C₄ carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase.
    Drawz SM, Taracila M, Caselli E, Prati F, Bonomo RA.
    Protein Sci; 2011 Jun 20; 20(6):941-58. PubMed ID: 21404358
    [Abstract] [Full Text] [Related]

  • 12. Dynamics of the metallo-beta-lactamase from Bacteroides fragilis in the presence and absence of a tight-binding inhibitor.
    Huntley JJ, Scrofani SD, Osborne MJ, Wright PE, Dyson HJ.
    Biochemistry; 2000 Nov 07; 39(44):13356-64. PubMed ID: 11063572
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Structure, Function of Serine and Metallo-β-lactamases and their Inhibitors.
    Salahuddin P, Kumar A, Khan AU.
    Curr Protein Pept Sci; 2018 Nov 07; 19(2):130-144. PubMed ID: 28745223
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Metallo-β-lactamase inhibitors by bioisosteric replacement: Preparation, activity and binding.
    Skagseth S, Akhter S, Paulsen MH, Muhammad Z, Lauksund S, Samuelsen Ø, Leiros HS, Bayer A.
    Eur J Med Chem; 2017 Jul 28; 135():159-173. PubMed ID: 28445786
    [Abstract] [Full Text] [Related]

  • 17. The crystal structure of the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia at 1.7 A resolution.
    Ullah JH, Walsh TR, Taylor IA, Emery DC, Verma CS, Gamblin SJ, Spencer J.
    J Mol Biol; 1998 Nov 20; 284(1):125-36. PubMed ID: 9811546
    [Abstract] [Full Text] [Related]

  • 18. NMR characterization of the metallo-beta-lactamase from Bacteroides fragilis and its interaction with a tight-binding inhibitor: role of an active-site loop.
    Scrofani SD, Chung J, Huntley JJ, Benkovic SJ, Wright PE, Dyson HJ.
    Biochemistry; 1999 Nov 02; 38(44):14507-14. PubMed ID: 10545172
    [Abstract] [Full Text] [Related]

  • 19. Crystal structure of extended-spectrum beta-lactamase Toho-1: insights into the molecular mechanism for catalytic reaction and substrate specificity expansion.
    Ibuka AS, Ishii Y, Galleni M, Ishiguro M, Yamaguchi K, Frère JM, Matsuzawa H, Sakai H.
    Biochemistry; 2003 Sep 16; 42(36):10634-43. PubMed ID: 12962487
    [Abstract] [Full Text] [Related]

  • 20. The 1.5-A structure of Chryseobacterium meningosepticum zinc beta-lactamase in complex with the inhibitor, D-captopril.
    García-Saez I, Hopkins J, Papamicael C, Franceschini N, Amicosante G, Rossolini GM, Galleni M, Frère JM, Dideberg O.
    J Biol Chem; 2003 Jun 27; 278(26):23868-73. PubMed ID: 12684522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.